Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.
John M. MaraganoreLocation
UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Alnylam Pharmaceuticals is implementing good security practices.
Read more about the latest issues in cybersecurity
Sensitive data is information that must be protected against unauthorized access. Access to ...
The dark web is a collection of websites that exist on encrypted darknet, overlay networks that ...
Compare Alnylam Pharmaceuticals's security performance with other companies